References
- Multiple Sclerosis Foundation. Epidemiology. Available at: http://www.msfocus.org/Facts-About-MS.aspx [Last accessed 11 Nov 2009]
- Lazoff M. Multiple sclerosis. Available at: http://emedicine.medscape.com/article/793013-overview [Last accessed 11 Nov 2009]
- Multiple Sclerosis International Federation. Epidemiology. Available at: http://www.msif.org/en/ [Last accessed 11 Nov 2009]
- Montalban X. The pros and cons of early treatment of relapsing forms of multiple sclerosis. J Neurol 2004;251:IV30-4
- Brandes DW, Callender T, Lathi E, et al. A review of disease-modifying therapies for MS: maximizing adherence and minimizing adverse events. Curr Med Res Opin 2009;25:77-92
- Goodin DS, Bates D. Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode. Mult Scler 2009;15:1133-4
- Coyle PK. Early treatment of multiple sclerosis to prevent neurologic damage. Neurology 2008;71:S3-7
- Porter R, Kaplan J, eds. Merck Manual online: Multiple Sclerosis. Available at: http://www.merck.com/mmpe/sec16/ch222/ch222b.html [Last accessed 21 Oct 2009]
- Miller JR. The importance of early diagnosis of multiple sclerosis. J Manag Care Pharm 2004;10:S4-11
- Kobelt G, Berg J, Atherly D, et al. Costs and quality of life in multiple sclerosis. A cross-sectional study in the United States. Neurology 2006;66:1696-702
- Whetten-Goldstein K, Sloan FA, Goldstein LB, et al. A comprehensive assessment of the cost of multiple sclerosis in the United States. Mult Scler 1998;4:419-25
- Julian LJ, Vella L, Vollmer T, et al. Employment in multiple sclerosis. Exiting and re-entering the work force. J Neurol 2008;255:1354-60
- Busche KD, Fisk JD, Murray TJ, et al. Short term predictors of unemployment in multiple sclerosis patients. Can J Neurol Sci 2003;30:137-42
- Roessler RT, Rumrill PD Jr, Hennessey ML, et al. Perceived strengths and weaknesses in employment policies and services among people with multiple sclerosis: results of a national survey. Work 2003;21:25-36
- Vogenberg FR, Holland JP, Liebeskind D. Employer benefit design considerations for the era of biotech drugs. J Occup Environ Med 2007;49:626-32
- Brook RA, Rajagopalan K, Kleinman NL, et al. Absenteeism and health benefit costs among employees with multiple sclerosis. Curr Med Res Opin 2009;25:1469-76
- Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83
- Wahlqvist P, Brook RA, Campbell SM, et al. Objective measurement of work absence and on-the-job productivity: a case–control study of US employees with and without gastroesophageal reflux disease. J Occup Environ Med 2008;50:25-31
- Cox E, Martin BC, Van Staa T, et al. Good research practices for comparative effectiveness research: Approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: The International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force report – Part II. Value Health 2009;12:1053-61
- Kleinman NL, Brook RA, Patel PA, et al. The impact of gout on work absence and productivity. Value Health 2007;10:231-7
- Gardner HH, Kleinman NL, Brook RA, et al. The impact of bipolar disorder on an employed population. J Clin Psychiatry 2006;67:1209-18
- SAS/STAT(R) 9.22 User’s Guide. ANOVA Procedure MEANS Statement. Available at: http://support.sas.com/documentation/cdl/en/statug/63347/HTML/default/viewer.htm#statug_anova_sect012.htm [Last accessed 5 Nov 2010]
- Kirschner N, Pauker S, Stubbs J. Information on cost-effectiveness: An essential product of a national comparative effectiveness program. Ann Intern Med 2008;148:956-61
- Kleinman NL, Rajagopalan K, Beren IA, et al. Medication adherence with disease modifying treatments for multiple sclerosis among US employees. J Med Econ 2010;13:633-40
- Reynolds MW, Stephen R, Seaman C, et al. Persistence and adherence to disease modifying drugs among patients with multiple sclerosis. Curr Med Res Opin 2010;26:663-74